COMPASS Pathways Archives

Psychedelics News

COMPASS Pathways

Press Releases

5 Nov 2020

COMPASS Pathways plc to announce third quarter 2020 financial results on 12 November 2020

London, UK, Nov....

By Microdose

Press Releases

4 Nov 2020

COMPASS Pathways plc to participate in Berenberg and Evercore investor conferences

London, UK, Nov....

By Microdose

Press Releases

26 Oct 2020

COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO

COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146....

By Microdose

Press Releases

22 Sep 2020

COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares

COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares Read more on Microdose...

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result